🇺🇸 FDA
Patent

US 12138274

Compositions and methods for the treatment of peripheral artery disease and cardiopulmonary diseases

granted A61KA61K31/506A61K31/5517

Quick answer

US patent 12138274 (Compositions and methods for the treatment of peripheral artery disease and cardiopulmonary diseases) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/506, A61K31/5517, A61K31/573, A61K31/65